Health System

A significant number of patients with chronic illnesses are not filling their prescriptions, according to a new study conducted by CVS Caremark and Horizon Blue Cross Blue Shield of New Jersey.

The FDA issued new label information on May 6 affecting all approved protease inhibitors for treatment of HIV when co-administered with colchicine (Colcrys, USP).

The FDA on April 29 announced the approval of sipuleucel-T (Provenge, Dendreon Corp.) for the treatment of certain men with prostate cancer, marking the first approval of a vaccine to treat cancer.

Even though Bruce Roberts strongly criticized pharmacy benefit managers (PBMs) during his tenure as executive vice president and CEO of the National Community Pharmacists Association (NCPA), he is enthusiastic about the prospect of heading up a type of PBM.

The American Pharmacists Association annual meeting opened in Washington just days before the big March vote on healthcare reform, and a number of people from the political realm were there to praise pharmacists and ask for their support.

FDA would like to alert healthcare providers to the recent proprietary name change for dexlansoprazole delayed-release capsules. Now known as Dexilant, dexlansoprazole is the proton pump inhibitor formerly known as Kapidex.

An overview of several provisions of "The Patient Protection and Affordable Care Act" affecting pharmacies and pharmacy practice.

Drug Topics' 2010 Chain of the Year award goes to Kerr Drug, a regional chain based in Raleigh, N.C.

Clinical pharmacy pioneer Mary Anne Koda-Kimble, PharmD, dean of the School of Pharmacy at University of California, San Francisco, was awarded the 2010 Remington Honor Medal, the highest honor given by the American Pharmacists Association, at its recent annual meeting in Washington.

A report issued by the Senate Finance Committee earlier this year noted that Avandia is associated with 83,000 excess heart attacks occurring between 1999 and 2007.

Compounded medicines - also called personalized solutions - have become an important element in many independent pharmacies.

Prescription-drug benefit plans prosper by exploiting a non-transparent, non-accountable system. This needs to change.

Supermarket chains Albertsons and Harris Teeter have launched online tools to help shoppers pursue health and wellness.

There is an answer to 12-hour shifts, inadequate support, 20-minute lunch hours, and no bathroom breaks. Ask the United Steelworkers of America.

Pharmacists speak out about job satisfaction, pharmacist shortage, and mail-order pharmacy.

While many people were trying to escape the scenes of death and destruction within Haiti, pharmacists Tamara Neff and Jess Streif were finalizing plans to travel there.

Here's one drug industry extravaganza that you won't forget in a hurry.

FDA announced that clopidogrel, an antiplatelet agent given to reduce the risk of heart attack, unstable angina, stroke, and cardiovascular death in patients with cardiovascular disease, will require a new black-box warning about its reduced effectiveness in patients who are poor metabolizers of the drug.

There is room for individual expression in our workplace; however, in a profession such as pharmacy, the main effort should be dedicated to patient care rather than how to successfully navigate the toxic personalities in the pharmacy.

More than 50 million Americans, including up to 40% of children, suffer from indoor and outdoor upper respiratory allergies. This year, several manufacturers have new offerings to control and treat asthma, allergy, and sinus symptoms.

In response to a flurry of drug thefts plaguing pharmaceutical manufacturers and distributors in recent months, the Center for Healthcare Supply Chain Research, an arm of the Healthcare Distribution Management Association (HDMA), is holding a seminar on Supply Chain Security May 10 and 11 in Alexandria, Va.

Seven metered-dose inhalers for treatment of asthma and chronic obstructive pulmonary disease will soon be phased out, according to FDA. The move goes along with U.S. commitments to the Montreal Protocol on Substances that Deplete the Ozone Layer.

A reformulation of controlled-release oxycodone (OxyContin, Purdue Pharma), designed to curb misuse and abuse of the drug, has received FDA approval.

Following FDA?s expanded indication for rosuvastatin (Crestor, AstraZeneca) in February, the drug?s producer now plans to extend the market for the drug by offering it as a preventive measure to people who do not have cholesterol issues.

Patients taking oral antidiabetes drugs who switched from exenatide twice daily to liraglutide once daily experienced further reductions in hemoglobin A1c and weight loss, according to the results of a clinical study.